Online follow-up for patients with papillary thyroid cancer
A Randomized Controlled Study of Online Outpatient Follow-up in Patients With Papillary Thyroid Cancer After Surgery
NA · West China Hospital · NCT06800482
This study is testing if online follow-up visits are just as good as in-person check-ups for people who have had surgery for papillary thyroid cancer.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 388 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | West China Hospital (other) |
| Locations | 1 site (Chengdu, Sichuan) |
| Trial ID | NCT06800482 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of online outpatient follow-up for patients who have undergone surgery for papillary thyroid cancer. It is a randomized, actively controlled, non-inferiority trial set to begin in August 2024 and run until August 2026. Participants must have had thyroid surgery and be able to complete follow-up visits online. The study aims to determine if online follow-up is as effective as traditional in-person visits for monitoring patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 90 who have undergone thyroid surgery for papillary thyroid cancer and can communicate in Chinese.
Not a fit: Patients who have a high risk of postoperative complications or cannot access the internet for follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a more convenient and accessible follow-up option for patients recovering from papillary thyroid cancer surgery.
How similar studies have performed: Other studies have shown promising results with online follow-up approaches, indicating potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria： * clinical diagnosis of papillary thyroid cancer * has underwent thyroid surgery (including endoscopic and open thyroid surgery) * 18 to 90 years of age * spoke Chinese * has the ability to use mobile phones and the Internet to complete the visit * voluntarily participate in clinical trials and sign informed consent. Exclusion Criteria： * postoperative hospital stay more than 5 days * inability to complete an online visit (no access to the device or the Internet * high risk of postoperative complications (recurrent laryngeal nerve injury, etc.) * unable to participate due to comorbidities, laboratory test results or physical disability * pregnancy * has mental illness or take psychotropic drugs, and were not able to perform the surgery
Where this trial is running
Chengdu, Sichuan
- West China Hospital — Chengdu, Sichuan, China (RECRUITING)
Study contacts
- Study coordinator: Jianyong Lei, Md
- Email: leijianyong@scu.edu.cn
- Phone: 86-19983137992
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Thyroid, Papillary Thyroid Cancer, Papillary thyroid cancer, surgery, out-patient